Patient perceptions of the re-usable Respimatt® Soft Mist™ inhaler in current users and those switching to the device: A real-world, non-interventional COPD study.

Abstract

PLAIN LANGUAGE SUMMARY:

Inhalers are often used to treat patients with chronic obstructive pulmonary disease (COPD). However, there are many available, which can lead to confusion and poor inhaler technique. It is important for a patient to be happy with their inhaler. This study looked at how patients liked the re-usable Respimat® Soft Mist™ inhaler vs. their previous inhaler. It also asked whether they would be willing to continue using the device at the end of the study period.After 4-6 weeks of using the re-usable device, patients reported that they were happy with the inhaler and most would be willing to carry on using it.Overall, these results show that doctors can prescribe Respimat re-usable to patients, even if the patient has not used the inhaler before.

• Authors: Michael Dreher, David Price, Asparuh Gardev, Pascale Peeters, Satish Arora, Simone van der Sar-van der Brugge, Richard Dekhuijzen, Omar S Usmani
• Journal: Chronic respiratory disease (Chron Respir Dis) 2021 Jan-Dec Vol. 18 Pg. 1479973120986228 ISSN: 1479-9731 [Electronic] England
• PMID: 33522304 (Publication Type: Journal Article)

Chemical References

• Bronchodilator Agents

Topics

• Administration, Inhalation
• Bronchodilator Agents (therapeutic use)
• Humans
• Nebulizers and Vaporizers
• Perception
• Pulmonary Disease, Chronic Obstructive (drug therapy)